desk
Share
News Topical, Digital Desk : Q2 Results: Pharma company Natco Pharma has released its results for the September quarter (Q2 FY26). Both profits and margins declined.
The company's consolidated profit declined year-on-year (YoY) from ₹677 crore to ₹518 crore during the quarter, a decline of approximately 23%. The company's consolidated revenue also declined marginally from ₹1,371 crore to ₹1,363 crore. The company's EBITDA declined from ₹804 crore to ₹579 crore during the quarter, while EBITDA margin fell from 58.7% to 42.5%. The company announced a dividend, providing relief to its shareholders, by declaring an interim dividend of ₹1.5 per share. Market analysts say the company will need to focus on margin improvement in the coming quarters, while management's dividend policy is a positive sign for shareholders. Share Performance Natco Pharma Limited shares fell today. The company's share price fell by 1.21% to close at ₹816.15, compared to the previous close of ₹826.15. During the trading session, the stock touched a high of ₹827.90 and a low of ₹807.00. The company's market capitalization is currently ₹14,620 crore and the dividend yield is 0.61%. Natco Pharma's 52-week high was ₹1,505.00 and low was ₹726.80. Today proved to be a weak day for investors, although fluctuations were seen throughout the session.
--Advertisement--
